| Bioactivity | Hylambatin, a tachykinin, increases both plasma glucose and plasma insulin, whereas the secretion of glucagon was not affected. Hylambatin can be used in diabetes research[1]. |
| Name | Hylambatin |
| CAS | 80890-46-6 |
| Sequence | Asp-Pro-Pro-Asp-Pro-Asp-Arg-Phe-Tyr-Gly-Met-Met-NH2 |
| Shortening | DPPDPDRFYGMM-NH2 |
| Formula | C63H90N16O19S2 |
| Molar Mass | 1439.61 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Güllner HG, et al. Hylambatin, a structurally unique tachykinin: effects on insulin and glucagon secretion. Arch Int Pharmacodyn Ther. 1984 Dec;272(2):304-9. |
Hylambatin
CAS: 80890-46-6 F: C63H90N16O19S2 W: 1439.61
Hylambatin, a tachykinin, increases both plasma glucose and plasma insulin, whereas the secretion of glucagon was n
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.